Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Stelis BiopharmaStelis Biopharma
VS
AUROBINDO PHARMA LTDAUROBINDO PHARMA LTD
Stelis Biopharma

Stelis Biopharma

Stelis Biopharma Pvt. Ltd. - Research Center, Bangalore, 560105, IN

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.stelis.com/
757/1000Fair

Stelis Biopharma is a leading, fully integrated biopharmaceutical contract development and manufacturing organization. The powerhouse to progress your biologic products to market as efficiently as possible, we can cater for the entire product lifecycle for our customers...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:448
Subsidiaries:6
12-month incidents
0
Known data breaches
0
Attack type number
0
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN

Last Update: 13/09/2026

View Profile
Between 750 and 799
https://www.aurobindo.com/
781/1000Fair

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,862
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Stelis Biopharma

Stelis Biopharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Stelis Biopharma in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AUROBINDO PHARMA LTD in 2026.

Incidents

Incident History - Stelis Biopharma (X = Date, Y = Severity)

Stelis Biopharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)

AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Stelis Biopharma

Stelis Biopharma

Incidents
No explicit notable incidents reported.
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced at least one data breach ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has experienced at least one vulnerability ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one holds the most compliance certifications ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one holds the fewest compliance certifications ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has the most subsidiaries ?
Between Stelis Biopharma company and AUROBINDO PHARMA LTD company, which one has the largest number of employees ?
Between Stelis Biopharma and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between Stelis Biopharma and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Stelis Biopharma or AUROBINDO PHARMA LTD ?
Which company is PCI DSS compliant - Stelis Biopharma or AUROBINDO PHARMA LTD ?
Between Stelis Biopharma and AUROBINDO PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between Stelis Biopharma and AUROBINDO PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94094
SUMMARY

A flaw has been found in OpenClaw up to 2026.9.5. Affected is the function createCanvasHostHandler of the file extensions/canvas/src/host/server.ts of the component Canvas Host Route. Executing a manipulation can lead to denial of service. The attack can be launched remotely. The exploit has been published and may be used. Fix suggestion's "streaming/size-limit" was never shipped - latest 2026.9.5 still buffers the whole file via readFile() (src/canvas/serve.runtime.ts:17,114), unlike the sibling WS path which caps at 64KB. The vendor was contacted early about this disclosure.

PUBLISHED
Date2026-09-20
UPDATED
Date2026-09-20
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:N/A:P
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-94093
SUMMARY

A security vulnerability has been detected in DLR-RM stable-baselines3 up to 2.9.0. This affects the function PPO.load/load_replay_buffer/VecNormalize.load of the file save_util.py. Such manipulation leads to deserialization. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used. In v2.9.0 the PyTorch tensor load path is hardened (weights_only=True), but that hardening was later reverted on master via PR #1913 "Hotfix: revert loading with weights_only=True" [blocked] to fix PyTorch 1.13 compat - so even the one "safe" path is inconsistent across versions. #2281 was closed as a duplicate of #1831 since both are unsafe pickle deserialization - but #1831's fix (PR #41) only gated the Hugging Face Hub loader in the separate huggingface_sb3 package. This finding covers the core stable_baselines3 load APIs (PPO.load, load_replay_buffer, VecNormalize.load), which have no safe mode or gate and remained exploitable in v2.9.0 until the outstanding hardening (PR #2264) ships.

PUBLISHED
Date2026-09-20
UPDATED
Date2026-09-20
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-94092
SUMMARY

A vulnerability was detected in dmlc dgl up to 2.1.0. This impacts the function load_info/_read_torch_data of the file utils.py. Performing a manipulation of the argument path results in deserialization. The attack can be initiated remotely. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-09-20
UPDATED
Date2026-09-20
RISK INFORMATION (Score: 5.5)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.1
CVE-2026-94091
SUMMARY

A weakness has been identified in piskvorky gensim up to 4.4.0. The impacted element is the function Load of the file gensim/utils.py of the component Model Loader. This manipulation of the argument fname causes deserialization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. Maintainer closed #3663 same-day with no comment, PR, or fix; repo's last push (2025-11-01) predates the report, so the unsafe pickle.load in SaveLoad.load remains unguarded at develop HEAD.

PUBLISHED
Date2026-09-20
UPDATED
Date2026-09-20
RISK INFORMATION (Score: 5.5)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.1
CVE-2026-94090
SUMMARY

A security flaw has been discovered in JusticeRage Manalyze 1.0.0. The affected element is the function PE::_parse_debug of the file manape/pe.cpp of the component PE Parser. The manipulation of the argument misc.Length results in integer underflow. The attack may be performed from remote. The patch is identified as 3e299685759f4f767088871de58c5d07f98ee382. A patch should be applied to remediate this issue.

PUBLISHED
Date2026-09-20
UPDATED
Date2026-09-20
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8